Addex Therapeutics Ltd
ADXN8.000USD
-0.380-4.53%
收盤 12/24, 13:00（美東）報價延遲15分鐘
7.77M總市值
虧損本益比TTM
關於 Addex Therapeutics Ltd 公司
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. It also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.
Addex Therapeutics Ltd簡介
公司代碼ADXN
公司名稱Addex Therapeutics Ltd
上市日期May 22, 2007
CEODyer (Tim)
員工數量2
證券類型Depository Receipt
年結日May 22
公司地址Chemin des Mines, 9
城市PLAN-LES-OUATES
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Switzerland
郵編1202
電話41228841555
網址https://www.addextherapeutics.com/en/
公司代碼ADXN
上市日期May 22, 2007
CEODyer (Tim)
Addex Therapeutics Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Dr. Isaac Manke
Dr. Isaac Manke
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Roger G. Mills
Dr. Roger G. Mills
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 11月15日 週六
更新時間: 11月15日 週六
持股股東
股東類型
持股股東
持股股東
佔比
GAMMA Investing LLC
0.01%
其他
99.99%
持股股東
持股股東
佔比
GAMMA Investing LLC
0.01%
其他
99.99%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
0.01%
其他
99.99%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
11
199.00
18.66%
--
2025Q3
13
199.00
18.82%
-178.00
2025Q2
13
377.00
18.92%
-12.73K
2025Q1
16
13.11K
17.74%
-176.53K
2024Q4
18
15.10K
16.53%
+13.71K
2024Q3
23
37.43K
17.28%
-1.01K
2024Q2
22
38.45K
22.31%
+2.01K
2024Q1
21
36.44K
17.06%
-145.91K
2023Q4
20
195.87K
5.59%
+122.48K
2023Q3
19
73.39K
85.88%
+23.16K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
GAMMA Investing LLC
121.00
0.01%
--
--
Sep 30, 2025
Rhumbline Advisers Ltd. Partnership
72.00
0.01%
--
--
Jun 30, 2025
SBI Securities Co., Ltd.
5.00
0%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
--
0%
-4.00
-100.00%
Dec 31, 2023
Citadel Advisors LLC
--
0%
-11.74K
-100.00%
Jun 30, 2025
Morgan Stanley & Co. LLC
100.00
0.01%
--
--
Jun 30, 2025
J. Stern & Co. LLP
--
0%
-107.83K
-100.00%
Mar 31, 2024
Armistice Capital LLC
--
0%
-43.00K
-100.00%
Mar 31, 2024
New Enterprise Associates (NEA)
--
0%
-9.00K
-100.00%
Mar 31, 2024
Adar1 Capital Management LLC
--
0%
-1.00K
-100.00%
Dec 31, 2024
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
公告日期
類型
比率
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
常見問題
Addex Therapeutics Ltd的前五大股東是誰？
Addex Therapeutics Ltd的前五大股東如下：
GAMMA Investing LLC持有股份：121.00佔總股份比例：0.01%。
Rhumbline Advisers Ltd. Partnership持有股份：72.00佔總股份比例：0.01%。
SBI Securities Co., Ltd.持有股份：5.00佔總股份比例：0.00%。
UBS Financial Services, Inc.持有股份：0.00佔總股份比例：0.00%。
Citadel Advisors LLC持有股份：0.00佔總股份比例：0.00%。
GAMMA Investing LLC持有股份：121.00佔總股份比例：0.01%。
Rhumbline Advisers Ltd. Partnership持有股份：72.00佔總股份比例：0.01%。
SBI Securities Co., Ltd.持有股份：5.00佔總股份比例：0.00%。
UBS Financial Services, Inc.持有股份：0.00佔總股份比例：0.00%。
Citadel Advisors LLC持有股份：0.00佔總股份比例：0.00%。
Addex Therapeutics Ltd的前三大股東類型是什麼？
Addex Therapeutics Ltd 的前三大股東類型分別是：
GAMMA Investing LLC
其他
GAMMA Investing LLC
其他
有多少機構持有Addex Therapeutics Ltd(ADXN)的股份？
截至2025Q4，共有11家機構持有Addex Therapeutics Ltd的股份，合計持有的股份價值約為199.00，占公司總股份的18.66% 。與2025Q3相比，機構持股有所增加，增幅為-0.16%。
哪個業務部門對Addex Therapeutics Ltd的收入貢獻最大？
在--，--業務部門對Addex Therapeutics Ltd的收入貢獻最大，創收--，占總收入的--% 。
